(Q41975512)

14 October 2017

1 reference

title

Norepinephrine: the next therapeutics frontier for Parkinson's disease (English)

1 reference

14 October 2017

0 references

1 reference

Peter A Lewitt

1

1 reference

14 October 2017

13 January 2012

1 reference

Translational Neurodegeneration

14 October 2017

1 reference

14 October 2017

1

1 reference

14 October 2017

1

1 reference

14 October 2017

4

1 reference

Creative Commons Attribution 2.0 Generic

14 October 2017

start time

13 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/2047-9158-1-4

0 references

cites work

The locus ceruleus norepinephrine system: functional organization and potential clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Norepinephrine: The redheaded stepchild of Parkinson's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

The brain-stem lesions in Parkinsonism

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Where does parkinson disease pathology begin in the brain?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

The role of the locus coeruleus in the development of Parkinson's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Cognitive deficits in Parkinson's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Oxidative stress: free radical production in neural degeneration.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506997

Peripheral beta-adrenergic blockade treatment of parkinsonian tremor

18 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2047-9158-1-4

Palliative therapy in the terminal stage of neurological disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2047-9158-1-4

CSF dopamine-beta-hydroxylase activity in Parkinson's disease

21 January 2018

1 reference

PubMed

12 December 2020

Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice

1 reference

PubMed

12 December 2020

Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1186/2047-9158-1-4

1 reference

PMCID

3506997

Dimensions Publication ID

14 October 2017

0 references

1 reference

14 October 2017

1 reference

PMCID

3506997